TransPerfect
Successful Market Navigation with Superior Translation

Any pharma company developing a lifesaving drug for patients must bear in mind that patients are scattered across the globe. Accordingly, to best engage and support those populations, their content needs to be in their native language. In this regard, pharma companies have always vied to translate and localize their content in a manner that helps patients, regulatory bodies, training staff, and healthcare providers in different regions navigate the global marketplace. But this has historically been cumbersome, complex, error-prone, and time-consuming. TransPerfect—an innovative translation and language service provider is on a mission to simplify translation processes for pharma companies. For the past 20 years, TransPerfect has been minimizing the otherwise erroneous and manual translation processes with a blend of innovative technologies and strategic partnerships.

TransPerfect entered the Veeva Alliance program in 2019 to create a partnership and develop integrations between GlobalLink and the Veeva Vault Platform. Over 5,000 of the world’s largest corporations trust GlobalLink to help them scale the localization of their international experiences.

In the wake of the pandemic’s catastrophic effects around the world, pharma companies are under constant pressure to reduce cycle times for bringing a drug to market. TransPerfect’s end-to-end translation management software, GlobalLink, is a proven solution trusted by more pharmas and biotechs than any other such platform. GlobalLink helps organizations streamline and simplify the translation process and automate historically manual tasks. This plus the ability to more effectively leverage translation memories and the combination of human and machine translation in the workflow makes the localization process more cost-efficient and reduces risk.

The X Factors

GlobalLink is a proprietary platform that leverages groundbreaking technologies such as AI and neural machine learning to provide a consistent and automated end-to-end translation process. It eliminates the need to download / upload files, manage multiple rounds of emails, automate translation review processes, and manually track offline translations. Using GlobalLink to automate manual steps, leverage linguistic assets, and incorporate machine translation typically results in 30 percent faster translation cycle time with improved quality and optimized resource utilization.

By integrating GlobalLink with Veeva Vault, TransPerfect has developed a certified integration to Veeva Vault Platform. Mutual customers can use multiple Veeva Products such as Vault RIM, Vault PromoMats, Vault MedComms, Vault QualityDocs, Vault SafetyDocs, and Vault Study Start Up to help speed the delivery timelines for drugs.

In addition, to ensure seamless integration and reinforce knowledge of Veeva Vault releases, TransPerfect has invested in certifying multiple Veeva White Belts who are trained specialists to monitor all technical and administrative needs related to translation.

The certified integration between GlobalLink and Veeva Vault keeps mutual clients’ proprietary content in a secure ecosystem throughout the translation process. The integration also helps organizations preserve the metadata associated with the translated content for complete traceability and auditability.

The Hallmark of Excellence

Over the years, TransPerfect has expanded its footprint to over 100 cities and 40 state-of-the-art production centers across six continents, giving way to a host of success stories to solidify its reputation as a leading translation management system provider.

In one instance, one of the top 20 pharma companies in the world was struggling to efficiently manage their decentralized translation process, which was impacting their translation quality, project deadlines, and visibility into spend and project metrics. They were also preparing for the EU CTR regulation and had to adhere to specific timelines. Considering the number of languages in which they had to submit their content for regulatory approval, the company decided to seek a better solution.

TransPerfect took charge of the project, designed a tailored solution for centralizing global translations within GlobalLink and integrated it with Veeva Vault. This resulted in a nearly 60 percent reduction in project management time, with the added benefit of accurate, real-time KPI tracking via Tableau. Meanwhile, by leveraging AI-powered workflows in GlobalLink, the client was able to reduce costs and shorten timelines, all while gaining the ability to scale and handle large volumes of content required for global regulatory approvals.

Reaching patients in their native language is a key priority for pharma and biotech companies, and GlobalLink’s ability to streamline translation processes and automate manual steps to reduce cycle times—all, seamlessly within Veeva Products is a game changer

For a company that believes in continuous innovation, TransPerfect invests a considerable amount of money to help their clients drive efficiency and mitigate risk. TransPerfect has developed specific functionality within GlobalLink to support the unique needs of sponsors and CROs handling varied clinical operations. It gains input from its clients to shape their roadmap and continuous improvement goals. In parallel, TransPerfect leverages its expertise in the bleeding edge of innovations such as AI and proprietary NMT neural machine engines, to drive further business efficiency and growth.

Staying abreast of industry trends, TransPerfect has taken note of how many MedTech companies are also trying to reap security, quality assurance, and promotional benefits associated with using the Veeva platform. Concurrently, MedTech, pharma companies manufacturing, direct-toconsumer goods, cosmetics, and other beauty products are also utilizing Veeva to clear regulatory approvals.